Ex-vivo Device for Screening the Efficacy of COVID-19 Vaccines and Producing Antibodies

COVID-19 has significantly impacted the health of the global population. Although timely detection and isolation are important, vaccination is probably more effective in fighting against COVID-19. Our proposed ex-vivo can help the validation of the COVID-19 vaccine and produce antibodies for COVID-19. The benefit to the Canadian community and the industry partner is palpable.

Faculty Supervisor:

Jie Chen

Student:

Partner:

Hidaca Ltd

Discipline:

Engineering

Sector:

Information and cultural industries; Manufacturing; Professional, scientific and technical services

University:

University of Alberta

Program:

Accelerate

Related projects

Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.

View all
Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects

Mitacs Partners

The strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.

Government
Academic
Industry
Innovation
International

International

Load More

International

Load More

Join a thriving innovation ecosystem.

Subscribe to our newsletter now!

Subscribe

Mitacs — Return on Innovation

Mitacs is funded by the Government of Canada, the Government of Alberta, the Government of British Columbia, Research Manitoba, the Government of New Brunswick, the Government of Newfoundland and Labrador, the Government of Nova Scotia, the Government of Ontario, Innovation PEI, the Government of Quebec, the Government of Saskatchewan, and the Government of Yukon.